Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach by unknown
COMPARISON OF THE DAMAGE-PROMOTING EFFECTS OF
LEUKOTRIENES DERIVED FROM EICOSAPENTAENOIC ACID
AND ARACHIDONIC ACID ON THE RAT STOMACH
By JOHN L. WALLACE AND G. WEBB McKNIGHT
From the Gastrointestinal Research Group, University of Calgary, Calgary,
Alberta, Canada T2N 4N1
While leukotrienes are classically considered to be mediators of inflammation,
their biological actions and the observation of increased production in some ex-
perimental models have led to the suggestion that they play a role in the pathogen-
esis of gastric ulceration (for a recent review, see reference 1). In recent years, there
has been considerable interest in the possibility of dietary manipulation of inflam-
matory diseases, especially through increasing the dietary intake of fish oils. The
rationale for these studies is that leukotrienes derived from the w-3 fatty acid ei-
cosapentaenoic acid (EPA), which is a major constituent of marine oils, are gener-
ally less potent, in terms of their proinflammatory actions, than those derived from
arachidonic acid (AA). For example, in one study, leukotriene 135 was reported to
be 10-30-foldless potent as a chemotactic factor for human neutrophils in vitro than
leukotriene B4 (LTB4) (2). There have been a number of recent reports of beneficial
effects of fish oil diets in experimental models of gastric and duodenal ulcer (3-7).
Whether or not these beneficial effects can be attributed to shifts in the production
of leukotrienes by the stomach (e.g., from LTB4 to LTB5) is not clear. This is in part
because the damage-promoting effects of the leukotrienes derived from EPA are not
known. The present study was therefore performed to characterize the effects of the
EPA-derived peptido-leukotrienes, LTC5 and LTD5, on the rat stomach, and to
compare these effects with the arachidonate-derived LTC4 and LTD4 .
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Materials and Methods
BriefDefinitive Report
Male Wistar rats with weights in the 180-220 g range were obtained from Charles River
Breeding Laboratories, Inc. (Montreal, Canada) and were fed standard chow pellets and
tap water ad libitum. For 18-22 h before an experiment, the rats were deprived of food, but
not water.
The rats were anesthesized with sodium pentobarbitone (60 mg/kg, i.p.). An ex vivo gas-
tric chamber preparation was used, as described in detail previously (8). This preparation
allows for direct viewing of the gastric mucosa throughout the experiment. Solutions can
be directly applied to the mucosa and subsequently withdrawn from the chamber. Trans-
mucosal potential differencewas recorded continuously during the experimentusing apparatus
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described previously (8). A carotid artery was cannulated for intra-arterial administration
of the leukotrienes. The leukotrienes were administered via this route so that first-passclear-
ance by the liver and lung could be avoided.
Effects on Susceptibility to Injury.
￿
At the beginning of the experiment, a blood sample (75
ul) was taken from the carotid cannula for determination ofresting hematocrit. Each experi-
ment consisted of six 10-min periods, with the solution bathing the mucosa (5.0 ml) being
changed at the beginning of each period. During all periods except the third, the mucosa
was bathed with 50 mM hydrochloric acid made isosmotic with mannitol. During the third
period, the mucosa was "challenged" with 20% ethanol (vol/vol). All luminal bathing solu-
tions were warmed to 37°C before being added to the chamber. At the end of each period,
the luminal bathing solution was removed by syringe, weighed, then frozen for subsequent
determination ofprotein concentration (9). An intra-arterial infusion ofone ofthe leukotrienes
or the vehicle was started at minute 17 (i.e., 3 min before the challenge with 20% ethanol)
and was continued for 5 min. The following leukotrienes were tested: leukotrienes C4, D4,
C5, and D5 . Leukotrienes C4 and D4 were tested at doses of 0.1, 1, and 3 ug/kg/min, while
leukotrienes Cs and D5 were tested at doses of 1, 3, and 5 /~g/kg/min. At the end of the ex-
periment, a second blood sample was taken from the carotid cannula for determination of
hematocrit. The mucosa was photographed usingcolor transparency film for subsequent plani-
metric determination of the surface area of the mucosa that exhibited hemorrhage (8).
Effects on Gastric BloodFlow.
￿
The rats were anesthetized and an ex vivo chamber was pre-
pared, as described above. Gastric bloodflow was measured using a laser-Doppler flowmeter,
as has been described in detail elsewhere (10). A hard-tip pencil probe (P-431; TSI Inc., St.
Paul, MN) was mounted in a micromanipulator over the chamber preparation . The probe
was connected to a flowmeter (BPM 403A; TSI Inc.) for continuous recording ofgastric blood
flow. The probe was lowered onto the mucosal surface, and basal recordings were made for
at least 20 min. The site of placement of the probe was random, except that it was always
placed within the corpus region. Blood flow was recorded continuously, and basal readings
were taken for at least 15 min before any leukotriene was tested. Each ofthe four leukotrienes
used in the studies described above were infused intra-arterially for a totalof3 min. For LTC4
and LTD4, the doses tested were 0.05, 0.1, and 1 gg/kg/min. For LTC5 and LTD5, the doses
tested were 0.1, 1, 2, and 5 ,ug/kg/min. After infusing one of the leukotrienes, gastric blood
flow was allowed to return to basal levels before another test was started. The order oftesting
of the different leukotrienes and doses within a preparation were randomized. Each dose of
each leukotriene was tested in at least four separate preparations.
Statistical Analysis.
￿
All data are expressed as the mean t SEM. Comparisons between
groups of data were made using the student's t test, with the exception of the changes in he-
matocrit, where a paired t test was used.
Materials.
￿
All leukotrienes were kindly provided by Dr. A. W Ford-Hutchinson of Merck-
Frosst Research Laboratories. The leukotrienes were stored in aliquots at - 70°C. On the
day ofan experiment, an aliquot was thawed and then diluted appropriately in PBS (pH 7.4).
Results
Effects on Susceptibility to Injury.
￿
The resting transmucosal potential difference (PD)
ranged between 45 and 55 mV (mucosa negative to serosa) in all experiments. In
control rats receiving intra-arterial PBS, the topical application of ethanol caused
a decrease in the PD of -30 mV followed by a gradual return to basal levels. By
the end of the experiment, 30 min after removal of 20% ethanol from the chamber,
the PD in the control group had recovered to 96 t 6% of basal levels. Hemorrhagic
erosions formed during the 30-min period after the challenge with 20% ethanol,
but were limited to the periphery of the chamber, and involved <1% of the total
glandular mucosa. The application of ethanol resulted in a marked increase in the
concentration of protein in the luminal bathing fluid, but in subsequent periods the
amount of protein efflux returned towards basal levels.Intra-arterial infusion of LTC4 or LTD4 at a dose of 0.1 hg/kg/min did not
significantly affect any ofthe three parameters ofmucosal damage, when compared
with the control group. However, when infused at doses of 1 or 3 /Ag/kg/min, both
LTC4 and LTD4 produced significant increases in hemorrhagic damage area (Fig.
1) and proteinefflux into theluminal solution (Fig. 2). Furthermore, the transmucosal
PD in rats receiving intra-arterial LTC4 or LTD4 at these doses did not return to
basal levels by the end of the experiment (Fig. 3). Significant differences between
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FIGURE 1.
￿
Extent ofhemorrhagic damage to the
gastricmucosa inducedby topically applied 20%
ethanol and intra-arterially infused leukotrienes.
Each leukotriene wasinfused, at thedosesshown,
for 5 min. In the control group receivingthe ve-
hicle intra-arterially, the damage area involved
<1% ofthe total glandular mucosa. Each point
represents themean f SEM ofat least four ex-
periments.
-0 LTC4
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FIGURE 3.
￿
Final transmucosal potential differ-
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kotriene intra-arterially and topical application
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￿
of20% ethanol. Thesepotentialdifference values
were taken 30 min afterthe removal of ethanol
from thegastricchamber. In thecontrol group,
the potential difference at the end oftheexperi-
ment was 96 t 6% ofthebasal level. LTC4 and
LTD4 caused significant (p < 0.05) reductions of
thefinalpotential difference when infusedat doses
of 1 or 3 kg/kg/min, whereas LTC5 and LTD5
only caused asignificant depression of potential
difference when infused at the5kg/kg/mindose.
Each pointrepresents themean t SEMofat least
DOSE INFUSED (lip/kq/mln)
￿
four experiments.
FIGURE 2.
￿
Effects of intra-arterial infusion of
variousleukotrienes on theleakage ofproteininto
thegastriclumenduring the30-min period after
topical application of 20% ethanol. The mean
protein leakage forthe control group, which re-
ceived thevehicle intra-arterially, is indicated by
the dotted line. LTC4 and LTD4 induced sig-
nificantly (p <0.05) more protein leakage than
the control group at dosesof 1 and3,ug/kg/min,
while LTC5 and LTD, significantly increased
proteinleakageonly atthe5,ug/kg/min dose. Each
point represents the mean ± SEMof at least four
experiments.1830
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the effects of similar doses of LTC4 and LTD4 were not observed with any of the
three parameters of damage.
Intra-arterial infusion of LTC5 or LTD5 at doses of 1 or 3 Ag/kg/min did not
significantly affect hemorrhagic damage area, the efflux of protein into the lumen,
or the recovery of transmucosal PD after topical application of 20% ethanol (Figs.
1-3). At a dose of 5 Wg/kg/min, both of the EPA-derived leukotrienes significantly
increased hemorrhagic damage area and protein efflux, while only LTC5 signifi-
cantly affected the recovery of PD towards basal levels.
Marked differences between the AA- and EPA-derived leukotrienes were also ob-
served when their effects on hematocrit were examined. For example, LTC4 and
LTD4 produced small, but significant (;6 < 0.05), increases in hematocrit at a dose
of 3 hg/kg/min (9 .6 ± 1 .5 0 Io and 12.3 t 3 .2%, respectively). On the other hand,
LTC5 and LTD5 did not produce significant changes in hematocrit at any of the
doses tested .
Effects on Gastric Blood Flow.
￿
Intra-arterial infusions of LTC4 or LTD4 for 3 min
produced marked reductions in gastric blood flow at doses of 0.1 or 1 Ag/kg/min
(Fig. 4). While there were not significant differences between the magnitude of the
reduction in blood flow with the two AA-derived leukotrienes, only LTD4 produced
a statistically significant reduction of flow at the dose of 0.1 wg/kg/min. At the dose
of 1 hg/kg/min, the two AA-derived leukotrienes reduced gastric blood flow by 40-60%.
Infusion of the two leukotrienes derived from EPA, at doses of 0.1, 1, or 2 Wg/kg/min,
did not significantly alter gastric blood flow (Fig. 4). At a dose of 5 Jig/kg/min, both
LTC5 and LTD5 produced significant decreases in flow, and there was no significant
difference between the two leukotrienes in terms of the magnitude of the reduction
of flow.
Discussion
Numerous studies have implicated a role for peptido-leukotrienes in the patho-
genesis of experimental gastric ulceration (1). While a link has never been conclu-
sively made, it is presumed that the vasoconstrictor actions of these leukotrienes in
the gastric submucosa are responsible for the observed ability of these compounds
to increase the susceptibility ofthe gastric mucosa to injury. It has further been sug-
gested that effects of peptido-leukotrienes on vascular permeability may contribute
to their "pro-ulcerogenic" actions (3) .
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FIGURE 4 .
￿
Effects of intra-arterial infusion of
various leukotrienes (for 3 min) on gastric blood
flow. Blood flow was measured by laser-Doppler
flowmetry, and the changes in blood flow as shown
represent the difference (percentage) between pre-
infusion and post-infusion levels. LTC4 signifi-
cantly (p < 0.05) reduced gastric blood flow at
doses of 0.1 and 1 hg/kg/min; LTD4 significantly
reduced flow at a dose of 1 14g/kg/min. LTC5
and LTD5 only produced a significant reduction
of gastric blood flow when infused at the 5
/Lg/kg/min dose. Each point represents the mean
± SEM of at least four experiments.WALLACE AND McKNIGHT
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Very little is known of the actions of the peptido-leukotrienes derived from EPA
in vivo, in particular, their actions on the stomach. Most previous studies on EPA
have focused on LTB4 vs. LTB5 (2, 11, 12), although there are also data from in vitro
studies of smooth muscle contractility to suggest that LTC5 is less potent as an
agonist than LTC4 (13). A number of recent studies have been performed in which
the effects of fish oil diets on the resistance ofthe gastric mucosa to injury have been
assessed (3-7). An underlying assumption of these studies is that the fish oil diet
modifies eicosanoid production such that prostaglandins with more potent protec-
tive actionsand/or leukotrienes with less potent pro-ulcerogenic actions areproduced.
The results of the present study show that there is indeed a clear difference in the
potency of leukotrienes derived from AA vs. those from EPA. Regardless of which
index of mucosal damage is used (i.e., damage area, protein efflux, PD), a similar
pattern was observed. There were also marked differences in potency between the
AA- and EPA-derived leukotrienes in terms of their effects on gastric blood flow.
LTC4 and LTD4 were at least five times more potent than LTC5 and LTD5 . It seems
likely that the changes in blood flow induced by the leukotrienes are an important
component ofthe mechanism ofaction of increasing susceptibility to injury by 20%
ethanol. It is possible, however, that other actions of these leukotrienes contributed
to the increased susceptibility to damage observed after their administration.
It should be noted that the addition of significant quantities of fish oil or pure
EPA to a diet will undoubtedly affect the synthesis of many other products besides
leukotrienes. Whether or notchanges in the synthesisof prostaglandins mayexplain
the observations of increased mucosal resistance to injury has not yet been deter-
mined, although one group has reported that an EPA-derived prostaglandin (PGF3«)
is, in fact, less potent as a protective agent than its AA-derived counterpart (PGF2a)
(14). Clearly, further studies are required not only to clarify the role of leukotrienes
in experimental and humangastrointestinal ulceration, but also to clarify themech-
anism through which the addition of EPA or fish oil to the diet results in increased
resistance of the gastroduodenal mucosa to injury.
Summary
The ability of leukotrienes derived from eicosapentaenoic acid were compared
with counterpartleukotrienes derived from arachidonic acid in termsoftheir ability
to affect susceptibility of the stomach to injury induced by a topical irritant and
their ability to alter gastric blood flow. Intra-arterial infusion of leukotriene C4
(LTC4) and LTD4 (0.1-3 Fig/kg/min for 5 min) produced dose-dependent increases
in gastric mucosal damage induced by topically applied 20% ethanol, as assessed
macroscopically, by changes in transmucosal potential difference and by measure-
ment of efflux of protein into the gastric lumen. Similar doses of LTC5 or LTD5
did not produce significant changes in any of these three parameters, when com-
pared with control rats receiving the vehicle. With a higher dose of LTC5 or LTD5
(5 Nag/kg/min), significant damage was observed. LTC4 and LTD4 were also found
to be more potent at reducing gastric blood flow than LTC5 and LTD5. These
results demonstrate that the peptido-leukotrienes derived from eicosapentaenoic acid
(LTC5 and LTD5) are on the order of five times less potent than the leukotrienes
derived from arachidonic acid (LTC4 and LTD4), in terms of increasing the sus-
ceptibility of the gastric mucosa to damage and reducing gastric blood flow. These1832
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results may have important implications in terms of the hypothesis that fish oil diets
may be protective or may accelerate healing in ulcerative diseases ofthe gastrointes-
tinal tract.
We thank Dr. A. W. Ford-Hutchinson of Merck-Frosst Canada Ltd. for the samples of the
leukotrienes.
Receivedfor publication 17 October 1989 and in revisedform 1 February 1990.
References
1 . Wallace,J. L. 1990. Lipid mediators ofinflammation in gastric ulcer. Am.J Physiol . 258:G1.
2 . Charleston, S., J. F. Evans, R. J. Zamboni, L. Leblanc, B. J. Fitzsimmons, C. Leveille,
P. Dupuis, and A. W. Ford-Hutchinson. 1986. Leukotriene B3, leukotriene B4 and leu-
kotriene B5: binding to leukotriene B4 receptors on rat and human leukocyte mem-
branes. Prostaglandins. 32:503.
3 . Pihan, G., C. Rogers, and S. Szabo. 1988. Vascular injury in acute gastric mucosal damage.
Mediatory role of leukotrienes. Dig. Dis. Sci. 33 :625.
4 . Leung, F. W. 1988. Fish oil protection against absolute ethanol induced gastric injury.
Gastroenterology. 94:A257.
5 . Faust, T. W., J. S. Redfern, E. Lee, and M. Feldman. 1989. Effects of fish oil on gastric
mucosal 6-keto-PGF,. synthesis and ethanol-induced injury. Am. J. Physiol. 257:G9.
6 . Guarner, F., J . Vilaseca, A. Salas, R. Rodriguez, M. Martinez, and J .-R. Malagelada.
1989. Prevention of cysteamine-induced duodenal ulcers by dietary fish oil. Gastroenterology.
96:A187.
7 . Schepp, W., B. M. Peskar, M. Trautmann, M. Stolte, F. Hagenmuller, V. Schusdziarra,
and M. Classen. 1989. Fish oil reduces ethanol-induced damage of the duodenal mucosa
in humans. Gastroenterology. 96:A446 .
8 . WallaceJ. L., G. P. Morris, E.J. Krausse, and S. E. Greaves. 1982. Reduction ofethanol-
induced gastric mucosal damage by cytoprotective agents: a correlated morphological
and physiological study. Can. J. Physiol. Pharmacol. 60 :1686.
9 . Bradford, M . M. 1976. A rapid and sensitive method for the quantification of micro-
gram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.
72:248.
10 . Kiel, J. W., G. L. Riedel, G. R. DiResta, and A. P. Shepherd. 1985. Gastric mucosal
blood flow measured by laser-Doppler velicometry. Am. J Physiol. 249:G539.
11 . Goldman, D. W., W. C. Pickett, and E. J. Goetzl. 1983. Human neutrophil chemotactic
and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.
Biochem. Biophys. Res. Commun. 117:282.
12 . Terano, T., J. A. Salmon, and S. Moncada. 1984. Biosynthesis and biological activity
of leukotriene B5. Prostaglandins. 27:217.
13 . Hammarstrom, S. 1980. Leukotriene C5: a slow reacting substance derived from ei-
cosapentaenoic acid. J. Biol. Chem. 255:7093 .
14 . Faust, T W., E. Lee, J . S. Redfern, and M. Feldman. 1989. Effect of prostaglandin F3,
on gastric mucosal injury by ethanol in rats: comparison with prostaglandin F2a.
Prostaglandins. 37:493.